Prosecution Pointer 359
By Publisher
Beginning on February 1, 2023, a new program at the USPTO expedites examination for a broad scope of technologies to prevent cancer and cancer mortality, in support of President Biden’s Cancer Moonshot. Patent applications pertaining to the qualifying technologies will be advanced out of turn for examination and will be reviewed earlier (accorded special status). The program is scheduled to run until either January 31, 2025, or the date by which the USPTO accepts a total of 1,000 grantable petitions (whichever is earlier). A link to more information can be found here.
Originally published at finnegan.com
Citation
Publisher, Prosecution Pointer 359, Prosecution First Blog (December 15, 2022) [The Library at LexBlog, LEX-WK-XCW6MHMB, lexpid.org/XCW6MHMB]
Filed under
Practice Area
Topic
Locations